Erlotinib is a pharmaceutical raw material used in the manufacture of medications for certain cancers, primarily non-small cell lung cancer and pancreatic cancer. It functions as an active pharmaceutical ingredient targeting specific genetic mutations in the epidermal growth factor receptor.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Erlotinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Erlotinib hydrochloride
pharmaceutical raw material
Ethyl 4-(8-chloro-3-hydroxy-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate
pharmaceutical raw material
Abarelix
pharmaceutical raw material
Befotertinib
pharmaceutical raw material
Ethacridine lactate
pharmaceutical raw material
4-(4-Bromo-2-fluoroanilino)-7-hydroxy-6-methoxyquinazoline
pharmaceutical intermediate
Neptinib
pharmaceutical raw material
(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-hydroxyquinazolin-6-yl)-4-(dimethylamino)but-2-enamide
pharmaceutical raw material
The international HS code for Erlotinib (CAS 183321-74-6) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
AAKJLRGGTJKAMG-UHFFFAOYSA-N
COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
Sourcing Erlotinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.